Oncology Therapies Of Chattanooga is categorized under Oncologists in Chattanooga, TN and active since 2010.
Oncology Therapies Of Chattanooga was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Stephen L Golder at the company’s single location by writing to 2333 Mccallie Avenue, Chattanooga, Tennessee TN 37404 or by phoning (423) 493-1690. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oncology Therapies Of Chattanooga |
| Contact Person: | Stephen L Golder |
| Address: | 2333 Mccallie Avenue, Chattanooga, Tennessee 37404 |
| Phone Number: | (423) 493-1690 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Oncology Therapies Of Chattanooga was started in 2010 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stephen L Golder for inquiries that concern Oncology Therapies Of Chattanooga by calling the company number (423) 493-1690, as your correspondence is most welcome. Additionally, the physical location of the single location of Oncology Therapies Of Chattanooga can be found at the coordinates 35.033568,-85.267999 as well as the street address 2333 Mccallie Avenue in Chattanooga, Tennessee 37404.
For its online presence, you may visit Oncology Therapies Of Chattanooga’s website at and engage with its social media outlets through on Twitter and on Facebook.